Stay updated with breaking news from Engineering Laboratory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An mRNA cancer vaccine developed at University of Florida may have the ability to reprogram the immune system against glioblastoma, findings of a first-in-human trial showed.The trial — results of which appeared in Cell— included four adults with immunotherapy-resistant MGMT unmethylated glioblastoma.
Army ERDC receives approval for four military construction projects
The recruitment for Earth Science High-talent in IDSSE, CAS job in Sanya, Hainan, China with Institute of Deep-sea Science and Engineering, Chinese Academy of Sciences. Apply Today.
The University's main news feed
Researchers introduced a new mRNA cancer vaccine that rapidly activates the immune system against glioblastoma, the deadliest form of brain tumor.